Cell-mediated lympholysis (CML) reactivity against the splenocytes of the kidney donor might be a good in vitro correlate of the homograft reaction. The present study was performed in an attempt to determine whether CML nonreactivity between unrelated donor-recipient combinations occurs and, if so, under what conditions.
HLA matching is able to improve graft survival in related donor-recipient combinations, but it is less effective for transplants in which donor and recipient are unrelated. Furthermore, both in related and unrelated donor-recipient combinations 30% or more of the renal transplants have good graft survival after 5 years, although they are mismatched for HLA-A and B. It is unclear why these major histocompatibility complex (MHC) nonidentical grafts are not rejected. Findings by others and our group suggest that survival of the graft even if MHC mismatches exist often coincides with donor-specific CML nonreactivity (1-6). Logically, one can postulate that the occurrence of CML donor-specific nonreactivity and good survival of MHC-mismatched grafts could be causally related. The present study attempts to document this and to delineate those factors which lead to donor-specific CML nonreactivity.
We will report on studies in which 20 unrelated donor-recipient combinations were investigated longitudinally (at various times before and after blood transfusion and renal allografting) and 45 who were studied only after transplantation.
Our results indicate that the development of CML donorspecific nonreactivity ir. the two groups of patients indeed correlates well with the good function of the graft. The occurrence of CML nonreactivity seems to be influenced by matching for HLA-B and to occur most frequently in male to male transplants. The results of mixed lympocyte cultures (MLCs) will be presented as well.
MATERIALS AND METHODS
Sixty-five donor-recipient combinations were investigated for their cytolytic potential (with the CML assay) and proliferative response (on the basis of the mixed lymphocyte reactions). Twenty patients that were studied prospectively received only one planned random blood transfusion before kidney transplantation; 19 patients were transfused with 1 unit of washed (i.e., leucocyte-poor) erythrocytes and 1 patient received 1 unit of buffy coat-free blood. The remaining 45 patients received more than one blood transfusion and were studied retrospectively. Nine of the 65 patients rejected their grafts, one patient died during transplantation. In three cases graft failure was attributable to nonimmunological or technical reasons. Three patients were studied after they had been given a second graft. All patients received immunosuppressive therapy consisting of azathioprine and prednisone. No antilymphocyte serum or antithymocyte globulin was used.
Lymphocyte preparation. Blood was coUected from the recipients in preservative-free heparin. For the longitudinal studies, serial samples of peripheral blood lymphocytes were collected from the recipients at several intervals, as follows: (1) immediately prior to blood transfusion, (2) at different times after blood transfusion, (3) on the day of transplantation, (4) at different intervals after transplantation, and (5) in the event of rejection, after transplantectomy. The lymphocytes were separated by Ficoll-Isopaque gradient centrifugation. Donor lymphocytes were obtained from the spieen without density centrifugation. All blood samples and the spieen cells of the specific kidney donors were frozen and stored in liquid nitrogen until tested.
MLC and CML techniques. Standard MLC and CML techniques were used in which the peripheral blood lymphocytes of the recipients were sensitized in vitro against the irradiated splenocytes of the specific kidney donor and against HLA-A, B-, C-, and DR-incompatible control cells of unrelated healthy subjects. MLC tests were performed with a microtechnique (7). The CML assay has been described previously in detail (8). Briefly, the effector cells (i.e., patient antidonor, patient anticontrol, control antidonor) were cultured for 6 days in tissue culture flasks.
The percentages of donor-specific lysis and control cell lysis were determined in relation to phytohemagglutinin-stiimilated blast cells, in a 4-hr 51 Cr assay. The percentage of lysis was calculated with the following formula: experimental mean cpm -spontaneous release mean cpm maximum release mean cpm -spontaneous release mean cpm X 100
The results are expressed on a scale in which the spontaneous release value was set to 0% and the maximum release value to
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GOULMY ET AL 211 lOüit {9) Standard errors of the means of trjphcates were always less than 5% Percentages equal to or below 10% were considered to be negative when only one effector to target ratio (50 J) was used Smce celJ numbers m several expenments were very Umited, positive and negative assignments were made on the basin of a 10% specific Cr releas,e value This cntenon is among others also the assignment of the European CML study group who aimed to standardize the CML technique (A compiehensive guxde to the European CML Workshops, report from the European CML study group, edited by Tom Kristensen, to be pubhshed) In order to hmit within expenmental Variation, all combinations with a given patient were tested on the same day in the same experiment
Besides the specific antidonor cytotoxicity, the cytolytic ca pacity of the reupient teils after pnming in vitro with fre&h or frozen unrelated HLA incompatible control cells were tested againsi these cells Furthermore, the lymphocytes of donors selected at random were used to test the stimulatory capacity of the splenocytes of the kidney donor in order to determine whether or not the CML nonreactivity could have been because of a defect in the stimulatory capacity of the kidney donor spienocyles
The culture medium for both the MLC and CML assays was KliMI 1640 supplemented with 20 mM Vglutamine, 100 XU of peniciJim per ml 100 μ% of streptomycm per ml, and 20% heat inactivated pooled human AB serum from male donors
Detection of suppresnor cells The protocol used to study a suppressive effect of the recipient lymphocytes was as follows Keapient lymphocytes (which showed donor CML nonreactiv lty after grafting) were mixed in a 1 1 ratio with lymphocytes obtanned at an earher date from the same recipient (a pretrans plant sample) Thereafter, they were cultured with irradiated splenocytes of the bpecific kidney donor and tested on the specific donor target cells accordmg to the above described protocol Detection of HLA Α, Β C, and DR antigens and screentng for HLA antibodies Typing for HLA-A, B, and C was performed with the Standard lymphocytotoxicity technique (10) Typing for the HLA-DR and the MBl, MB2, and MB3 antigens were performed with the two-color fluorescence test (11) Screemng for HLA-A, B, and C antibodies was performed usmg the Standard lymphocytotoxicity technique Sigmficance testmg The χ λ test with Yates' correction was used throughout the study RKSULTS Table 1 hsts the variables sex of recipient and donor, ABO blood group, rhesut. blood group, and HLA-A, B, C, and DR types of the 20 patients studied who had received one Single planned blood transfusion pnor to transpianfcation If only one ΗΪ Α DE antigen was recognized, it was assumed that the patient and/or donor were homozygous for that antigen This was considered permissible because the sum of the gene frequen< les of HLA-DRl to w8 is close to 1 0 in The Netherlands (van Iiood et al submitted for pubhcation) Only patient 17 had formed ieukocyte antibodies The antidonor MLC reactivity (expressed m cpm X 10 ') and the percentage of lysis in CML against the cells of the kidney donor of each mdividual patient at different intervals before and after blood transfusion and after transplantation are hsted Ten of the 15 patients with functiomng grafts with a follow up time of at least 60 days after transplantatmn became negative in the CML test against the splenotytes ol the kidney donor, although they were positive in this test with the lymphocytes from random donors In eight patients with a negative CML test against specific donor splenocytes 60 days oi moie post transplantation, earlier samples were positive with the same donor cells, thus suggestmg the induction of donor-speufic CML nonreactivity Three of the patients with functiomng grafts still showed a positive CML test in their most recent samples Α pretransfusion blood sample was avaüable for 19 of the 20 patients and the CML test results obtamed with those samples were compared with the results obtamed with one or two blood samples collected between blood transfusion and transplantation In some mstanees, the CML reactivity showed a tendency to mcrease 14 days after blood transfusion, followed by a decrease in CML reactivity 3 weeks after the transfusion Α difference of 5% or less, which was the level of Standard error of triphcates, was considered to be not significant This transient rise in CML is m agreement with earlier more extensive kinetic studies reported by Charmot ei al (12) The antidonor MLC activity measured as a prohferative response by 'H-thymidine mcorporation is also shown in Table  1 Some patients displayed a decrease, others an mcrease, or only a shght change in MLC activity before and after the blood transfusion In about one-third of the donor recipient combinations, a decrease of MLC reactivity was observed 14 days after blood transfusion Arbitrarily, only a decrease of 30% or more was considered to be significant Furtheimore, in the longitudinal Uudies, we observed that if after transplantation the antidonor MLC reactivity dimmished, it dimmished also against donors selected at random This is m contrast to the antidonor CML reactivity aftei transplantation which seemed to be kidney donor specific An example of this phenomenon is shown m Figure 1 , where it can be seen that, while the anticontro] cell CML reactivity remained positive, the antidonor CML reactivity after transplantation is low This is in contrast to the MLC test which became low against both Table 2 summanzes the relevant CML data and vanables for 45 patients given two or more blood transfusions before transplantation Forty of 45 patients had functiomng grafts for more than 1 year, 5 patients rejected their grafts CML results obtained with blood samples taken before transplantation were avaüable for only a few patients and are noc shown In several mstanees two blood samples were tested at different times after transplantation Donor specific CML nonreactivity was ob served in 28 of the 45 patients, in 9 of them 2 to Z2 months post-transplantation and in the remaining 19 more than 1 year after transplantation In the 12 nonrejeeting patients who re mained positive in the antidonor CML test, the percentage of kill ranged from 14 to 78
The question as to whether the fraction of patiepts which become CML nonreattive mereases after transplantation (2, 13) cannot yet be answered In the group given only one blood transfusion, 11 of 15 functiomng grafts became nonresponsive within 12 months post-transplantation and m the multitransfused group 19 of 28 were nonresponsive within the same penod The duration of the penod in which a patient develops cellular nonreattivity post transplantatton can differ between mchviduals Table 3 shows that the oecurrence of CML nonreactivity did not significantly correlate with the difference between one and more than one pretransplant blood transfusions CML reattivity, when it oecurs, with some exceptions, rarely amounts to rnore than 35% after the first few weeks posttransplantation We observed nine cases in which it was substantially higher In five cases the high values coincided with a Among the patients who rejeeted their grafts (a total of nme for the two groups) five showed extremeiy high leveJs of iysis in the CML assay (=80%) after transplantectomy against the spieen cells of their donor These high levels of cytotoxic effector cells persisted for more than 450 days after transplan teetomy Since 70% of our nonrejecting patients demonstrated CML nonreactivity the frequency of CML nonreactivity in a non transplanted control group of 31 responder and iarget cells with sirmlar HLA mibmatches was examined In this group only 10% had a negative CML test (data not shown) which is significantly lower than in our patient matenal but is about the same as the oecurrence of CML nonreactivity obtained with pretransfusion blood samples (Table 1 10%) In the combmations in which the recipients antidonor Iysis were negative we never observed positive Iysis of donor cells after in vitro sensitization of the recipient lymphocytes with the lymphocytes of third party cells Furthermore Stimulation of recipient lymphocytes to«vard a pool of stimulator cells obtained from five unrelated donors (pool Stimulation) with subsequent testmg on the specjfit kid ney donor splenocytes as target cells induced no cytolytic activity of the recipient lymphocytes against the sperific donor cells CML results of the pool Stimulation of four patients are shown in Table 4 It has been suggested that donor specific CML nonreactivity is attnbutable to the presence of suppressor cells (14) How ever we Lould demonstrate suppressor cell activity in only one {Table 5 patient 1) of seven patients studied Α decrease of specific antidonor Iysis from 54 to 21% in the mixture with the pretransplant sample was observed In order to deterrmne what factors could be predictive of donor specific CML nonreactivity the CML results from the patients were compared with all of the variables shown in Tables 1 and 2 Table 6 gives the signifitant and/or informative % lysis oc donor specific CML reactivity V V γ α control cell CML reactivity so -ι(κ10 3 cpm) MLC pattern rec xdonor, to-· ο time in days TiGUiir 1 Longitudmal CML and MLC study patterns of cytotoxic and prohferaüve roaponses agimst donor and control cells Ί he patient reeuved two HLA Α and Β compatible blood transfusions pnor to troated for two reversible rejection cnses (on and pr p reeuved two HLA Α and Β compatible blood transfusions pnor to transplantaüon He was, troated for two reversible rejection cnses (on days 7 and 58 post transplantation) and was released from the hospital h d f function on day 8d post transplantaüon · proliferative results A statistical analysis of all variables which could influence the occurrence of CML nonreactivity was performed for 55 nonrejecting patients Nine cases of rejection and one patient who died durmg transplantauon were excluded from the anal ysis 1 he results indicate clearly that CML nonreactivity is indeed influenced by several factors The best correlation with CML nonreactivity is good kidney function as judged by labo ratory tests (creatimne clearance, etc) and chnical judgment Furthermore kidneys from male donors into male recipients do better than all other possible sex combinations Compatibihty for HLA Β is also sigmficantly associated with CML nonreac tivity I he presence of HLA DR4 m the recipient shows a trend which is not yet sigmficant for the occurrence of the CML nonreactivity With regard to the presence of particular HLA antigens in the donor, we found that CML reactivity seems to occur more often in the presence of HLA-DR2 or DR3 antigen on donor lymphocytes Matching for MB was not sigmficantly ι-orrelated with CML. nonreactivity (see Table 7 )
DISCUSSION
The CML results obtained in our patients can be divided into three groups group 1 with extremely high percentages of lysis in patients who rejected their graft, group 2 with weakly positive CML values (>10 to 30%) often correlated with a poorer func tion of the grafted kidney, and group 3 compnsing the CML nonreactive recipients with the highest number of good func tioning grafts (see Table 6 ) Specific antidonor CML nonreactivity has been descnbed also by other authors (1-4, 6 ), but most of the reports concern post transplant studies in related donor recipient combinations The phenomenon of CML nonreactivity occurs, as is shown in this study, in unrelated donor recipient pairs as well
In 39 of our 65 transplant patients, we found donor specific CML nonreactivity at vanous times after transplantauon, which in this study was defined as < 10% lysis against the splenocytes of the specific kidney donor Donor specific non reactivity can occur quite soon after transplantauon, m some instances even within 14 days Almost all of the recipients fahowed a normal cytolytic capacxty toward HLA incompatible control cells In only one ca^e the anticontrol cell lysis remained low in repeated expenments (Table 1 , patient 2) This might have been because of the influence of immunosuppressive drugs on the MLC and CML activity as postulated by Keown et el {14) That is certamly not the cause of the donor specific CML nonreactivity in the other 38 patients However, the po^ibdity cannot be excluded that immunosuppressive drugs influence the proliferative capacity of the patients lymphocytes Für thermore, dimimshed prohferation cannot explain the inabihty to develop cytotoxic effector cells We have observed previously (15) that, even with a low Stimulation >ndex in MLC, strong lysis can occur In the present study, the specific antidonor Ή thymidme uptake in the patients who rejected their grafts showed low prohferation and extremely high cytotoxic activity in some cases Although a drop in MLC reactivity toward the kidney donor splenocytes after blood transfusion was observed in about one-fourth of the patients (Table 1) , this decrease does not seem to correlate with the occurrence of donor specific CML nonreactivity
The following factors could explain the occurrence of CML nonreactivity in more than one-half of the grafted recipients Preoperative blood transfusions could be one such factor CML nonreactivity occurs with the same frequency m the both Single and multitransfused patients However, a nontransfused control group i & lacking, although patient 19 (Table 1) and patients 42 and 45 (Table 2 ) received only buffy coat-free transfusions Such blood transfusions have been shown to be unable to r<°duce graft facilitation (16) and all three grafts were rejected In addition, suppressor cells could be responsible for the CML nonreactivity However, we have been able to demonstrate the presence of suppressor cells in only one of seven cases studied In an attempt to identify the variables which predispose for the induction of donor specific CML nonreactivity we investi gated as many variables as possible As shown in Table 6 several factors appeared to have a signlficant influence on the occurrence of CML nonreactivity The best correlatlon was found between CML nonreactivity and good kidney function +73  +30  +25  +32  +43  +12  +36  +47  +J5  +53  +11  +46  +21  +83  +15  +73  +79  +66  +35  +40  +44  +80  +73  +68  +27  +34  +22  +33  +79  +72  +87  +48  +74  +22  +29  +38  +29  +31  +21  +57  +29  +100  +92  +98  +35 SO?i DR?* indicates the SD and DR antigens which were mismatched between donor and recipient ' Stcond graft Patient 41 rejeeted his second graft Patients42 44 and 45 rejeeted their first grafts because of uncontrollablc allograft rejection I ransplantectomy was performed in patient 43 because of thrombopenia and cytomegaly infection *• Ί χ transplantcctomy (χ 10 186) This indicates that what has been studied IS mdeed thmtally relevant More studies are needed however to deter minc lts vilue m renal transplantation The followmg factors showed also a significant correlation sex match-a male reup lent who received a male graft had the greatest chance to btcome CML nonreactive and HLB Β locus antigen matchcompatibihty between donor and reupient for the HLB Β locus antigtns increased the chance for the development of CML nonreactivity These two factors remforce each other (see Table  S ) Furthermore, CML nonreactivity imght also be influenced by the presence of HLA DR4 antigen on the recipient lympho cytes (Table 6 ) Conversely, the presence of HLA DR2 and DR3 on donor lymphocytes comcides with a positive CML Duquesnoy et al (17) recently have reported that compati bihty between donor and recipient for the MB antigens (which are Β cell antigens different from but tlosely hnked to the HLA DR antigens) seemed to be correlated with successful transplants and CML nonreactivity in mtrafamüial donor and reciplent combmations We were not able to confirm that findmg in unreiated combmations (see Table 7 )
Immunogenetic studies are under way to define more pre 
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' As responder cells, the pretransplantation and CML nonreactive post transplantation blood samples were mixed in a 11 ratio (onh one ratio has been carried out) 
